In contrast, modern GLP-1 receptor agonists have shown cardiovascular benefits in high-risk patients
These intertwined epidemics have previously been strongly associated with cardiovascular complications, but more recent research suggests that these metabolic conditions may further trigger or exacerbate malignancy (cancers)
Research shows that patients eating high-protein, nutrient-dense meals experience better tolerance, sustained energy, and faster metabolic adaptation
However, artificially increasing GLP-1 activity can lead to metabolic imbalances that affect other hormone systems, including leptin, ghrelin, thyroid hormones (T3 and T4), and parathyroid hormone (PTH), all of which play essential roles in weight management and bone health
S.SrensenM